Lofexidine: A Newly FDA-Approved, Nonopioid Treatment for Opioid Withdrawal.

Bennett DoughtyDaralyn MorgensonTracy Brooks

Published in: The Annals of pharmacotherapy (2019)

Lofexidine is an effective and safe agent in treating symptoms related to opioid withdrawal in adults when compared with placebo; although it is more widely accessible than other first-line therapies, its use in practice may be limited by cost.

Keyphrases

chronic pain
pain management
primary care
healthcare
randomized controlled trial
physical activity
combination therapy
drug administration
study protocol
depressive symptoms